You are here

  • Home
  • Archive
  • Volume 20, Issue 2
  • Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary: A JGOG Study

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary: A JGOG Study

 

Online download statistics by month:

Online download statistics by month: December 2018 to September 2024

AbstractFullPdf
Dec 20181600
Jan 20191201
Feb 20191400
Mar 2019801
Apr 2019600
May 20192200
Jun 2019901
Jul 20191801
Aug 20191400
Sep 20192003
Oct 20192600
Nov 2019901
Dec 20191400
Jan 20202801
Feb 20201101
Mar 2020800
Apr 20201200
May 20202903
Jun 20202301
Jul 20204600
Aug 20202700
Sep 20202700
Oct 20202000
Nov 20202000
Dec 20201800
Jan 20214600
Feb 20212700
Mar 20212501
Apr 20214300
May 20211400
Aug 2021100
Oct 20212201
Nov 20211000
Dec 20212801
Jan 20224201
Feb 20221400
Mar 20223404
Apr 20221800
May 20224800
Jun 20224600
Jul 20222900
Aug 20226600
Sep 20224800
Oct 20224400
Nov 20224300
Dec 20225200
Jan 20236401
Feb 20237700
Mar 20231100
Apr 20233802
May 20232100
Jun 20231700
Jul 2023600
Aug 20232100
Sep 20234300
Oct 20231200
Nov 20232600
Dec 20234000
Jan 20241200
Feb 20244200
Mar 20242300
Apr 20242100
May 202410501
Jun 20242200
Jul 20243000
Aug 20243800
Sep 2024800
Total1834026